CA Patent

CA2455585A1 — Compounds for treating anhedonia

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2003-02-20 · 23y expired

What this patent protects

The invention relates to the use of dopamine antagonists for the production of medicaments to eliminate and/or relieve anhedonia.

USPTO Abstract

The invention relates to the use of dopamine antagonists for the production of medicaments to eliminate and/or relieve anhedonia.

Drugs covered by this patent

pramipexole-dihydrochloride (PRAMIPEXOLE DIHYDROCHLORIDE)

Patent Metadata

Patent number: CA2455585A1
Jurisdiction: CA
Classification: —
Expires: 2003-02-20
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim Pharma GmbH and Co KG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.